Efficacy and safety of Aviandr in the treatment of anxiety in patients with adjustment disorders after COVID-19

20245 citationsJournal Article

Authors

Veronika B. Popova · Samara Medical Institute Reaviz

Elizaveta A. Antonova · Institute of Experimental Cardiology

P M Hlyabova · Xenobe Research Institute

Irina S. Rodyukova · Pirogov Russian National Research Medical University

D.N. Alpenidze · St. Petersburg State Medical Academy "City Polyclinic №44"

Yu.V. Drozdova · St. Petersburg State Medical Academy "City Polyclinic №44"

Abstract

According to the results of the study, the anxiolytic, antidepressant, antiasthenic and pro-cognitive effects of Aviandr were observed. An increase in the social activity of patients was observed.

Topics & Keywords

COVID-19 and Mental Health Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes Mindfulness and Compassion Interventions

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: S S Korsakov Journal of Neurology and Psychiatry

Volume 124, Issue 7, pp. 131-131

DOI: 10.17116/jnevro2024124071131

Field-Weighted Citation Impact: 3.20